en
Scientific article
Open access
French

[Angiology and haemostasis. Highlights on some new data in 2017]

Published inRevue médicale suisse, vol. 14, no. 588-589, p. 19-22
Publication date2018
Abstract

New data support the fact that prophylactic anticoagulation with direct oral anticoagulants is effective and safe for the long-term prevention of venous thromboembolism. This type of treatment is dedicated for a subgroup of patients only, which is described in this article. With regard to major bleedings occurring with these anticoagulants, new data have been added to those already available for idarucizumab, a specific antagonist of dabigatran. Finally, we summarize the data regarding a breakthrough molecule, emicizumab, which could potentially open a new era in the management of people with haemophilia A.

Citation (ISO format)
FONTANA, Pierre et al. [Angiology and haemostasis. Highlights on some new data in 2017]. In: Revue médicale suisse, 2018, vol. 14, n° 588-589, p. 19–22.
Main files (1)
Article (Published version)
Identifiers
ISSN of the journal1660-9379
324views
63downloads

Technical informations

Creation11/13/2018 11:59:00 AM
First validation11/13/2018 11:59:00 AM
Update time03/15/2023 3:20:30 PM
Status update03/15/2023 3:20:30 PM
Last indexation02/12/2024 12:58:27 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack